Clinical Trials
30 trialsEscrimHEMA
University Hospital, Angers
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
REVERSE_2021
Azienda USL Reggio Emilia - IRCCS
FEAD
Helse Stavanger HF
Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
Caja Costarricense de Seguro Social
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
Henan Cancer Hospital
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Sheba Medical Center
ETCABIO
University Hospital, Angers
NexCAR19
Health Institutes of Turkey
EHCancer
Zagazig University
ACL ALL
ASL Lecce
Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
Region Stockholm
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
National Medical Research Center for Therapy and Preventive Medicine
Anti CD19 Gene Therapy for B-cell Lymphoma
Anhui Provincial Hospital
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Linperlisib Combined With Chidamide in Patients With PTCL
Henan Cancer Hospital
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma
Henan Cancer Hospital
EPOCH
Hospital General de Mexico
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
ALHERT
University Hospital, Angers
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
Tel-Aviv Sourasky Medical Center
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
Singapore National Eye Centre
Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging
Kocaeli City Hospital
MSTH-CAR002
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Tel-Aviv Sourasky Medical Center